Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,153
archived clinical trials in
Gout

Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Aurora, CO
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Bridgeport, CT
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Washington,
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Decatur, GA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Decatur, GA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Coeur D Alene, ID
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Coeur D Alene, ID
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Indianapolis, IN
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Louisville, KY
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Metairie, LA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Metairie, LA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Baltimore, MD
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Boston, MA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Rochester, MN
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
St. Joseph, MO
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Helena, MT
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Helena, MT
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Omaha, NE
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
New York, NY
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Ashville, NC
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Ashville, NC
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Cleveland, OH
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Portland, OR
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Charleston, SC
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Dallas, TX
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Norfolk, VA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated:  7/16/2012
Clinical Research Facility
mi
from
Seattle, WA
Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Long-Term Rilonacept Treatment for the Prevention of Gout Flares
Status: Enrolling
Updated: 7/16/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Aurora, CO
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Honolulu, HI
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Louisville, KY
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Jackson, MS
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
New York, NY
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Bismarck, ND
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Bismarck, ND
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Cleveland, OH
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Tulsa, OK
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Dallas, TX
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated:  11/16/2012
Clinical Research Facility
mi
from
Seattle, WA
Open-Label Lesinurad Monotherapy Extension Study in Gout
A Long-Term Open-Label Extension Study for Subjects Completing a Phase 3 Efficacy and Safety Study of Lesinurad Monotherapy in Subjects With Gout
Status: Enrolling
Updated: 11/16/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Morehouse School of Medicine
mi
from
Atlanta, GA
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Morehouse School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Harvard University
mi
from
Cambridge, MA
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Harvard University
mi
from
Cambridge, MA
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
Baylor College of Medicine
mi
from
Houston, TX
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated:  1/8/2013
University of Vermont
mi
from
Burlington, VT
Using Allopurinol to Relieve Symptoms in Patients With Heart Failure and High Uric Acid Levels
Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients
Status: Enrolling
Updated: 1/8/2013
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Single and Multiple Dose Study in Japanese
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of Lesinurad in Healthy Male Japanese Subjects
Status: Enrolling
Updated:  3/6/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Single and Multiple Dose Study in Japanese
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of Lesinurad in Healthy Male Japanese Subjects
Status: Enrolling
Updated: 3/6/2013
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated:  5/6/2013
Clinical Research Facility
mi
from
Birmingham, AL
Combining Lesinurad With Allopurinol in Inadequate Responders
A Phase 3 Randomized, Double-Blind, Multicenter, Placebo- Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects With Gout Who Have Had an Inadequate Hypouricemic Response to Standard of Care Allopurinol
Status: Enrolling
Updated: 5/6/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials